Pain pills vs. cancer treatment: new study investigates opioid impact on immunotherapy
NCT ID NCT07188857
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how opioid painkillers affect the success of immunotherapy in 100 people with advanced lung cancer who have moderate to severe pain. Researchers want to see if better pain control helps immunotherapy work better, and whether opioids themselves change the treatment's effectiveness. The goal is to gather knowledge, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- opioid drugs
- What this could lead to
- If it works, this could help doctors understand whether pain control or opioids themselves influence how well immunotherapy works.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find a clear link, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Can patients safely dispense their own pain medicine after surgery?
- Parkinson's pain: could a new Add-On drug bring relief?
- Can pictures capture how chronic pain disrupts daily life?
- Could a simple choice sheet curb unneeded opioid prescriptions?
- Can a pill outperform chemo for a Hard-to-Treat lung cancer mutation?